4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-18-035180
EVP & Chief Commercial Officer gave up 294 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Dallas Jayson Donald Alexander · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-01 | Shares withheld for taxes : show line 1 in the form | −294 | $73.73 | $21,677 | 23,830 | D |
Loading xslF345X03/doc4.xml…